JP2010520213A5 - - Google Patents

Download PDF

Info

Publication number
JP2010520213A5
JP2010520213A5 JP2009551834A JP2009551834A JP2010520213A5 JP 2010520213 A5 JP2010520213 A5 JP 2010520213A5 JP 2009551834 A JP2009551834 A JP 2009551834A JP 2009551834 A JP2009551834 A JP 2009551834A JP 2010520213 A5 JP2010520213 A5 JP 2010520213A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
patient
pharmaceutically acceptable
acceptable salt
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009551834A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010520213A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/055207 external-priority patent/WO2008106569A1/en
Publication of JP2010520213A publication Critical patent/JP2010520213A/ja
Publication of JP2010520213A5 publication Critical patent/JP2010520213A5/ja
Withdrawn legal-status Critical Current

Links

JP2009551834A 2007-03-01 2008-02-28 高ナトリウム食の患者における高血圧の処置のためのレニン阻害剤 Withdrawn JP2010520213A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89238907P 2007-03-01 2007-03-01
PCT/US2008/055207 WO2008106569A1 (en) 2007-03-01 2008-02-28 Renin inhibitors for the treatment of hypertension in patients with high sodium diet

Publications (2)

Publication Number Publication Date
JP2010520213A JP2010520213A (ja) 2010-06-10
JP2010520213A5 true JP2010520213A5 (cg-RX-API-DMAC10.html) 2011-04-14

Family

ID=39509896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009551834A Withdrawn JP2010520213A (ja) 2007-03-01 2008-02-28 高ナトリウム食の患者における高血圧の処置のためのレニン阻害剤

Country Status (3)

Country Link
US (1) US20100120921A1 (cg-RX-API-DMAC10.html)
JP (1) JP2010520213A (cg-RX-API-DMAC10.html)
WO (1) WO2008106569A1 (cg-RX-API-DMAC10.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004100871A2 (en) * 2003-05-09 2004-11-25 Pharmacia Corporation Combination of an aldosterone receptor antagonist and a renin inhibitor

Similar Documents

Publication Publication Date Title
JP2023002662A5 (cg-RX-API-DMAC10.html)
RU2470016C2 (ru) Производное бипиразола
EP2248519A3 (en) Non-mucoadhesive film dosage forms
RU2012118974A (ru) Комбинации ингибитора pi3k и ингибитора мек
JP2011528713A5 (cg-RX-API-DMAC10.html)
JP2010077141A5 (cg-RX-API-DMAC10.html)
FI3716979T3 (fi) 4-pyrimidiinisulfamidijohdannaisen ja SGLT-2-inhibiittorin yhdistelmä endoteliiniin liittyvien sairauksien hoitamiseksi
TW200833663A (en) Therapeutic agents
RU2013111077A (ru) Дипептидное пролекарство, его применение и лекарственное средство
NZ587202A (en) Methods for measuring a patient response upon administration of a drug and compositions thereof
FI3164125T3 (fi) Menetelmiä ja koostumuksia liikalihavuuden hoitamiseksi, painonnousun ehkäisemiseksi, painonpudotuksen edistämiseksi, laihtumisen edistämiseksi tai diabeteksen hoitamiseksi tai sen kehittymisen ehkäisemiseksi
RU2013119607A (ru) Полициклические гетероциклические соединения и способы их применения для лечения вирусных заболеваний
JP2019515908A5 (cg-RX-API-DMAC10.html)
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
JP2021521118A5 (cg-RX-API-DMAC10.html)
JP2007504168A5 (cg-RX-API-DMAC10.html)
JP2009517411A5 (cg-RX-API-DMAC10.html)
JP2023531675A5 (cg-RX-API-DMAC10.html)
JP2006511538A5 (cg-RX-API-DMAC10.html)
JP2023531930A5 (cg-RX-API-DMAC10.html)
WO2007145863A3 (en) Sustained release formulation of naltrexone
RU2008127882A (ru) Лечение пищевода барретта
RU2007119067A (ru) Средство для лечения синдрома раздраженного кишечника с преобладанием диареи
EA200601286A1 (ru) Фармацевтические композиции, содержащие ингибитор протонового насоса и прокинетический агент
JP2014503589A5 (cg-RX-API-DMAC10.html)